Posts tagged with ‘marine microbe’

  • Solazyme and Bunge Sign JDA Partnership for Production of Renewable Triglyceride Oils

    Solazyme, Inc., a leading renewable oils and bioproducts company, today announced a two-year joint development agreement (JDA) with Bunge Limited (NYSE: BG) to develop microbe-derived oils utilizing Brazilian sugar cane feedstock. The agreement builds on Bunge’s earlier equity investment in Solazyme, and the letter of intent signed by both firms in December 2010 that contemplates a manufacturing joint venture for the production […]
    0
  • New Marine Drugs Issue Available

    MDPI AG Announces the new issue of Marine Drugs is now avaiable. Mar. Drugs, Volume 9, Issue 2 (February 2011), Pages 154-293 http://www.mdpi.com/1660-3397/9/2/ Table of Contents:   Dexin Kong, Takao Yamori, Motomasa Kobayashi and Hongquan Duan Article: Antiproliferative and Antiangiogenic Activities of Smenospongine, a Marine Sponge Sesquiterpene Aminoquinone Mar. Drugs 2011, 9(2), 154-161; doi:10.3390/md9020154 http://www.mdpi.com/1660-3397/9/2/154   Xiang-Rong Tian, Hai-Feng Tang, […]
    0
  • SAMS and Aquapharm sign marine products agreement

    AQUAPHARM Biodiscovery, a leading marine biotechnology company, has announced it has signed a long-term agreement with the Scottish Association for Marine Science (SAMS) to discover, develop and launch new marine products derived from marine micro-organisms. Under the terms of this agreement, SAMS will provide Aquapharm with privileged access to the vast array of marine samples that it has collected from […]
    0
  • US: Newsweek Magazine showcases hunt for medical cures underwater

    Advances in technology are making it easier and increasingly profitable to hunt for drugs in the ocean. Marine bioprospectors, as they’re known, are scouring coral reefs, deep-sea trenches, and everything in between.  David Newman, chief of the natural products branch at the National Cancer Institute (NCI), estimates that at least 30 research teams are experimenting with marine-derived compounds for treating cancer, […]
    0
  • Joint investigation by Aquapharm and Leatherhead seeks to uncover new natural preservatives from marine bacteria and fungi

    A new joint investigation by Aquapharm and Leatherhead is seeking to uncover new natural preservatives from marine bacteria and fungi. Aquapharm Biodiscovery believes its substantial collection of marine bacteria and fungi from a variety of diverse sources could offer some solutions. It has teamed up with Leatherhead Food International to develop a source of naturally-derived anti-microbial compounds. Based at the […]
    0
  • Biological Materials of Marine Origin Publication Now Available

    Dr. Hermann Ehrlich, Dresden University of Technology, Dresden, Germany, has published “Biological Materials of Marine Origin”, available now via Springer. This text is the first ever to offer a coherent analysis of the nature, origin and evolution of biocomposites and biopolymers found within the broad variety of marine invertebrate organisms and their unusual structural formations. It is an interdisciplinary look […]
    0
  • MDPI Office of the Publisher announces new issue of Marine Drugs

    MDPI is pleased to announce the publication of the following issue: Mar. Drugs, Volume 8, Issue 9 (September 2010), Pages 2435-2545 at http://www.mdpi.com/1660-3397/8/9/ Table of Contents: Paola Laurienzo Review: Marine Polysaccharides in Pharmaceutical Applications: An Overview Mar. Drugs 2010, 8(9), 2435-2465; doi:10.3390/md8092435 http://www.mdpi.com/1660-3397/8/9/2435 Till F. Schäberle, Emilie Goralski, Edith Neu, Özlem Erol, Georg Hölzl, Peter Dörmann, Gabriele Bierbaum and Gabriele […]
    0
  • Aquapharm and Dundee University Sign Research Collaboration to find Marine Compounds to target Alzheimer’s

    Aquapharm Biodiscovery, a leading marine biotechnology company, recently announced it has signed a research agreement with Dundee University to help it develop new drugs based on marine natural products that may help in the fight against Alzheimer’s. Alzheimer’s is a disease marked by the formation of insoluble protein aggregates in the brain with associated progressive degeneration of the neurons. The […]
    0
  • 5th International Conference on Marine Bioprospecting in Tromso; 23-25th February 2011

    BIOPROSP is a leading international biennial conference series on bioprospecting from cold marine environments. These conferences aim to present explorative research and its industrial applications in an integrated fashion. The focus in the 2011 conference will be industrial biotech and bioprospecting as a stepping stone towards the bioeconomy. Target group: Academic and industry researchers, decision makers, regulatory experts, investors and public […]
    0
  • Trius Therapeutics Awarded U.S. Department of Defense Contract to Develop Novel Antibiotics from Marine Natural Product Libraries

    Trius Therapeutics, Inc. today  that it has been awarded a new four and a half year contract from the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, for the development of novel antibiotics directed against gram-negative bacterial pathogens. Trius may receive up to $29.5 million in support of development efforts under the new DTRA contract, which […]
    0